Susquehanna International Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.5M Sell
979,600
-630,800
-39% -$43.9M 0.01% 1131
2025
Q4
$107M Buy
1,610,400
+150,200
+10% +$9.71M 0.01% 840
2025
Q3
$98.3M Buy
1,460,200
+543,200
+59% +$43M 0.01% 905
2025
Q2
$80M Buy
917,000
+456,400
+99% +$35.8M 0.01% 878
2025
Q1
$31.5M Sell
460,600
-135,600
-23% -$11.1M 0.01% 1344
2024
Q4
$46.4M Buy
596,200
+31,700
+6% +$2.35M 0.01% 1177
2024
Q3
$37.8M Buy
564,500
+191,400
+51% +$15.7M 0.01% 1287
2024
Q2
$42.3M Sell
373,100
-1,152,200
-76% -$146M 0.01% 1095
2024
Q1
$212M Sell
1,525,300
-2,300
-0.2% -$289K 0.04% 388
2023
Q4
$190M Buy
1,527,600
+650,400
+74% +$66.4M 0.04% 418
2023
Q3
$81.8M Buy
877,200
+223,200
+34% +$25.2M 0.02% 717
2023
Q2
$84M Buy
654,000
+87,500
+15% +$10.6M 0.02% 699
2023
Q1
$65.8M Sell
566,500
-397,500
-41% -$44.5M 0.01% 793
2022
Q4
$109M Buy
964,000
+528,100
+121% +$58M 0.03% 512
2022
Q3
$35.1M Buy
435,900
+37,700
+9% +$3.19M 0.01% 1011
2022
Q2
$29.7M Sell
398,200
-1,143,000
-74% -$104M 0.01% 1158
2022
Q1
$197M Sell
1,541,200
-1,084,800
-41% -$119M 0.03% 404
2021
Q4
$353M Buy
2,626,000
+865,200
+49% +$124M 0.05% 302
2021
Q3
$241M Buy
1,760,800
+233,200
+15% +$29.4M 0.03% 445
2021
Q2
$163M Buy
1,527,600
+226,000
+17% +$21.7M 0.02% 592
2021
Q1
$117M Sell
1,301,600
-1,310,000
-50% -$123M 0.02% 661
2020
Q4
$241M Buy
2,611,600
+1,164,000
+80% +$104M 0.04% 368
2020
Q3
$149M Sell
1,447,600
-47,200
-3% -$4.93M 0.03% 427
2020
Q2
$151M Buy
1,494,800
+721,200
+93% +$64.5M 0.04% 375
2020
Q1
$52.1M Sell
773,600
-1,426,400
-65% -$88.8M 0.02% 641
2019
Q4
$120M Buy
2,200,000
+1,152,800
+110% +$54.7M 0.03% 419
2019
Q3
$39.1M Buy
1,047,200
+536,000
+105% +$20.8M 0.01% 881
2019
Q2
$19.1M Sell
511,200
-229,200
-31% -$7.2M 0.01% 1313
2019
Q1
$22M Buy
740,400
+364,400
+97% +$12.8M 0.01% 1125
2018
Q4
$11.3M Sell
376,000
-436,400
-54% -$13.8M ﹤0.01% 1504
2018
Q3
$29.1M Buy
812,400
+553,600
+214% +$17.2M 0.01% 1041
2018
Q2
$6.14M Sell
258,800
-58,400
-18% -$1.24M ﹤0.01% 2479
2018
Q1
$5.88M Buy
317,200
+18,000
+6% +$266K ﹤0.01% 2344
2017
Q4
$4.29M Sell
299,200
-362,800
-55% -$4.72M ﹤0.01% 2715
2017
Q3
$8.1M Sell
662,000
-158,800
-19% -$2.81M ﹤0.01% 1974
2017
Q2
$15M Buy
820,800
+561,200
+216% +$10.4M 0.01% 1369
2017
Q1
$5.5M Buy
259,600
+103,200
+66% +$2.01M ﹤0.01% 2258
2016
Q4
$2.33M Buy
156,400
+4,000
+3% +$70.9K ﹤0.01% 3747
2016
Q3
$3.34M Sell
152,400
-84,000
-36% -$1.87M ﹤0.01% 2747
2016
Q2
$4.69M Sell
236,400
-52,800
-18% -$899K ﹤0.01% 2294
2016
Q1
$4.91M Buy
289,200
+148,000
+105% +$2.47M ﹤0.01% 2323
2015
Q4
$2.89M Sell
141,200
-807,200
-85% -$16.8M ﹤0.01% 3350
2015
Q3
$20.4M Buy
948,400
+308,400
+48% +$6.88M 0.01% 1192
2015
Q2
$12.8M Buy
640,000
+79,200
+14% +$1.39M 0.01% 1727
2015
Q1
$8.74M Buy
560,800
+269,200
+92% +$4.07M ﹤0.01% 2009
2014
Q4
$4.01M Buy
291,600
+41,600
+17% +$509K ﹤0.01% 3204
2014
Q3
$2.5M Buy
250,000
+138,400
+124% +$1.41M ﹤0.01% 4218
2014
Q2
$1.11M Sell
111,600
-11,200
-9% -$99.2K ﹤0.01% 5830
2014
Q1
$1.27M Sell
122,800
-61,600
-33% -$637K ﹤0.01% 5096
2013
Q4
$1.63M Sell
184,400
-109,200
-37% -$864K ﹤0.01% 4629
2013
Q3
$2.07M Buy
+293,600
New +$1.86M ﹤0.01% 4034

Other funds holding DXCM

Susquehanna International Group's DXCM Position: Q1 2026 in Review

Susquehanna International Group reduced its DexCom (DXCM) stake by 27% in Q1 2026, selling an estimated $9.6M and leaving 378,706 shares worth $23.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2012.

Susquehanna International Group first reported a position in DXCM in Q3 2013 and has held it in 49 quarters since. The position peaked at $136M in Q4 2021. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Susquehanna International Group held 378,706 shares of DexCom worth $23.8M as of Q1 2026.
  • Susquehanna International Group sold 137,900 DexCom shares in Q1 2026, an estimated $9.6M.
  • DexCom made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2012 holding.
  • Susquehanna International Group first reported a position in DexCom in Q3 2013 and has held it in 49 quarters since.
  • Susquehanna International Group's DexCom position peaked at $136M in Q4 2021.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.